EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Foregut malignancy after discordant fecal immunochemical test: A cohort study at a United States safety-net hospital

Andrew John Cruz, Sandeep Gurram, Isabel Obias, Allen Luo, Gevork Salmastyan, Aravind Rajagopalan, Stefanie Bui, Roxanna Sharifi, Nikhilesh Kumar, Chester Hui, Erick Cruz Grave, Eric Yang, Amarachi Erondu, Theodor Griggs

World Journal of Gastrointestinal Oncology · 2026-11-15 · 18 (11)

DOI: 10.4251/wjgo.123432 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Whether fecal immunochemical test-positive (FIT+) patients whose colonoscopy does not identify a bleeding source should undergo esophagogastroduodenoscopy (EGD) is unclear. Prior data report foregut cancer rates below 1% in population screening cohorts, but yield by colonoscopy concordance has not been directly compared, particularly in United States safety-net Hispanic populations. AIM To compare the yield of EGD between FIT+ patients with discordant (non-explanatory) and concordant (explanatory) colonoscopy at a safety-net hospital. METHODS We performed a retrospective cohort study of FIT+ adults aged ≥ 45 years who underwent colonoscopy (2019-2025) and EGD within one year at Los Angeles General Medical Center, a safety-net hospital. Colonoscopy was classified as concordant if it identified a lesion plausibly explaining a FIT+ result, including colorectal neoplasia, vascular lesions, or colitis. Foregut malignancy and other EGD findings were compared between groups. Firth penalized logistic regression (exploratory) adjusted for age, sex, anemia, foregut symptoms, nonsteroidal anti-inflammatory drug/aspirin use, and cirrhosis. RESULTS Of 379 FIT+ patients (172 discordant, 207 concordant), 11 foregut malignancies occurred in the discordant group (6.4% vs 0%; P < 0.001; Firth adjusted odds ratio = 26.14, 95%CI: 2.16-315.82). Premalignant lesions were more common in concordant patients (7.7% vs 2.3%, P = 0.02); other EGD findings did not differ significantly between groups. Foregut symptoms were equally prevalent in both groups (44.2% vs 38.2%, P = 0.25), indicating that symptom-driven referral does not account for the observed difference. Among the 11 malignancy patients, 0 were ever-smokers and All patients underwent EGD for standard clinical indications; the observed association reflects a clinically selected cohort rather than protocolized EGD for all discordant patients. CONCLUSION In a clinically selected safety-net cohort, all foregut malignancies occurred exclusively among discordant FIT+ patients despite similar symptom profiles between groups, suggesting that discordant colonoscopy may help stratify foregut malignancy risk in populations with elevated gastric cancer burden.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →